Chemical–Chemical
Redox Cycle Signal Amplification
Strategy Combined with Dual Ratiometric Immunoassay for Surface-Enhanced
Raman Spectroscopic Detection of Cardiac Troponin I
Improving the sensitivity and reproducibility of surface-enhanced
Raman spectroscopy (SERS) methods for the detection of bioactive molecules
is crucial in biological process research and clinical diagnosis.
Herein, we designed a novel SERS platform for cardiac troponin I (cTnI)
detection by a chemical–chemical redox cycle signal amplification
strategy combined with a dual ratiometric immunoassay. First, ascorbic
acid (AA) was generated by enzyme-assisted immunoreaction with a cTnI-anchored
sandwich structure. Then, oxidized 4-mercaptophenol (ox4-MP) was reacted
with AA to produce 4-mercaptophenol (4-MP). Quantitative analysis
of cTnI was realized by a Raman signal switch between ox4-MP and 4-MP.
Specifically, AA could be regenerated by reductant (tris(2-carboxyethyl)
phosphine, TCEP), which in turn produced more signal indicator 4-MP,
causing significant signal amplification for cTnI analysis by SERS
immunosensing. Moreover, a dual ratiometric-type SERS method was established
with the intensity ratio I1077/I822 and I633/I822, which improved the reproducibility of the
cTnI assay. The excellent performance of the chemical–chemical
redox cycle strategy and ratio-type SERS assay endows the method with
high sensitivity and reproducibility. The linear ranges of cTnI were
0.001 to 50.0 ng mL–1 with detection limits of 0.33
pg mL–1 (upon I1077/I822) and 0.31 pg mL–1 (upon I635/I822), respectively.
The amount of cTnI in human serum samples yielded recoveries from
89.0 to 114%. This SERS method has remarkable analytical performance,
providing an effective approach for the early diagnosis of cardiovascular
diseases, and has great latent capacity in the sensitive detection
of bioactive molecules.